Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: A Phase 1 Study to Evaluate the Safety and Clinical Activity of Intravesicular CAVATAK™ (Coxsackievirus A21, CVA21) Alone and in Sequential Combination With Low Dose
Brief Summary: The study will consist of 2 sequential parts. Part A is a study of the safety and tolerability of CAVATAK administered via intravesical instillation in patients with non-muscle invasive bladder cancer scheduled to undergo TUR. Part B will evaluate the safety and tolerability of CAVATAK administered in sequential combination with low dose Mitomycin C in the same patient population.